Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets
Clinical trial NCT04693039 · COMPLETED
Trial details
- NCT number
- NCT04693039
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2021-10-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.